Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2023
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
3,613
-36.64%
|
$2,890,400
$800.0 P/Share
|
|
Feb 06
2023
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,613
+26.82%
|
$1,741,466
$482.68 P/Share
|
|
Feb 06
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
752
-0.17%
|
$594,080
$790.24 P/Share
|
|
Feb 03
2023
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,021
-45.02%
|
$795,359
$779.0 P/Share
|
|
Feb 03
2023
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,021
+31.04%
|
$387,980
$380.95 P/Share
|
|
Feb 03
2023
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
3,286
-13.93%
|
$2,543,364
$774.29 P/Share
|
|
Feb 03
2023
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.49%
|
$1,350,000
$270.43 P/Share
|
|
Feb 03
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,248
-6.4%
|
$1,739,952
$774.29 P/Share
|
|
Feb 03
2023
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.87%
|
$1,143,000
$381.92 P/Share
|
|
Feb 03
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
739
-2.25%
|
$564,596
$764.5 P/Share
|
|
Feb 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$75,700
$757.46 P/Share
|
|
Feb 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-4.75%
|
$827,200
$752.19 P/Share
|
|
Feb 01
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.53%
|
$409,200
$372.46 P/Share
|
|
Jan 27
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1
-0.08%
|
$747
$747.0 P/Share
|
|
Jan 27
2023
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.08%
|
$520
$520.01 P/Share
|
|
Jan 06
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
3,070
-71.11%
|
$2,293,290
$747.14 P/Share
|
|
Jan 06
2023
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,070
+41.56%
|
$1,596,400
$520.01 P/Share
|
|
Jan 04
2023
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
291
-0.23%
|
-
|
|
Jan 03
2023
|
Arthur F Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+0.85%
|
-
|
|
Jan 03
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$72,700
$727.0 P/Share
|
|
Jan 03
2023
|
George L Sing Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+0.63%
|
-
|
|
Jan 03
2023
|
Christine A Poon Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+7.49%
|
-
|
|
Jan 03
2023
|
Joseph L Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+2.57%
|
-
|
|
Jan 03
2023
|
Michael S Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.69%
|
-
|
|
Jan 03
2023
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.69%
|
-
|
|
Jan 03
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-4.75%
|
$793,100
$721.86 P/Share
|
|
Jan 03
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.53%
|
$409,200
$372.46 P/Share
|
|
Jan 03
2023
|
Craig B. Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+11.14%
|
-
|
|
Jan 03
2023
|
N Anthony Coles Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.6%
|
-
|
|
Jan 03
2023
|
Huda Y Zoghbi Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.69%
|
-
|
|
Jan 03
2023
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
330
+6.35%
|
-
|
|
Dec 28
2022
|
N Anthony Coles Director |
SELL
Open market or private sale
|
Direct |
5,758
-17.57%
|
$4,099,696
$712.52 P/Share
|
|
Dec 28
2022
|
N Anthony Coles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,758
+37.19%
|
$2,464,424
$428.4 P/Share
|
|
Dec 20
2022
|
P Roy Vagelos Director |
SELL
Discretionary transaction
|
Indirect |
141
-3.39%
|
$102,789
$729.29 P/Share
|
|
Dec 16
2022
|
P Roy Vagelos Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,651
+0.51%
|
-
|
|
Dec 16
2022
|
Christopher R. Fenimore VP Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,926
+9.39%
|
-
|
|
Dec 16
2022
|
Robert E Landry EVP Finance CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,853
+10.5%
|
-
|
|
Dec 16
2022
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Grant, award, or other acquisition
|
Direct |
2,752
+10.64%
|
-
|
|
Dec 16
2022
|
Marion Mc Court EVP Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
2,973
+11.87%
|
-
|
|
Dec 16
2022
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
4,129
+6.36%
|
-
|
|
Dec 16
2022
|
Neil Stahl EVP Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,101
+2.03%
|
-
|
|
Dec 16
2022
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Grant, award, or other acquisition
|
Direct |
3,798
+10.08%
|
-
|
|
Dec 12
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
264
-1.36%
|
$192,720
$730.17 P/Share
|
|
Dec 09
2022
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-1.46%
|
$185,991
$753.28 P/Share
|
|
Dec 09
2022
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-1.61%
|
$370,476
$753.28 P/Share
|
|
Dec 09
2022
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-0.89%
|
$350,898
$753.28 P/Share
|
|
Dec 09
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-0.86%
|
$370,476
$753.28 P/Share
|
|
Dec 09
2022
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
57
-0.02%
|
$42,921
$753.28 P/Share
|
|
Dec 09
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-2.36%
|
$370,476
$753.28 P/Share
|
|
Dec 09
2022
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-1.39%
|
$206,322
$753.28 P/Share
|